In this week’s issue:
- Please see the attached message from the Office of the Vice-President Research & International regarding Award Updates, Resources & Ideas for Faculty members.
- Please see the attached message from Dr. Gavin Stuart regarding the Call for Nominations for 2015 Faculty of Medicine Awards
- MedU – Letters of Intent for Medical Education Research
- MitoCanada Foundation – Mitochondrial Disease Research Grant
- US National Institute on Drug Abuse & partners – Canada Addiction Medicine Research Fellowship
- ALS Association – Phase II Clinical Development of Novel ALS Treatments
Awards and Honours:
- Japan Prize Foundation – Japan Prize
- LSI Public Talks – Drugs, Diet and Genes. Personal Approaches to Treat Diabetes and Obesity
LOI Deadline: December 12, 2014
MedU, a nonprofit medical education organization, advances medical education through the collaborative development, maintenance, and research of innovative and comprehensive computer-assisted instruction programs.
Through its Research Grants program, the organization will award two to five grants of up to $25,000 each for research — both qualitative and quantitative — in the areas of learning analytics, instructional design, and effectiveness studies. Preference will be given to multi-institutional and cross-disciplinary studies. Projects should be completed in one or two years. For approved grants, MedU will provide in-kind grant support for data access and analysis needed to achieve the research goals.
To be eligible, applicants must be an M.D., Ph.D., or Ed.D. investigator. Principal investigators not at the doctorate level will need a letter of support from a doctorate-level research sponsor.
Please visit the MedU website for further details.
MitoCanada Foundation – Mitochondrial Disease Research Grant
Deadline: December 15, 2014
MitoCanada Foundation will fund application(s) that are determined to be relevant to the following research priority areas:
- Enhanced identification of patients with mitochondrial disease through metabolic, proteomic or genetic testing.
- Therapeutic strategies for Mitochondrial Disease patients with a focus on nutritional/nutraceutical or pharmacological approaches (e.g., mitochondrial cocktail, novel anti-oxidant strategies, higher protein diets) and exercise and related areas (e.g., efficacy of strength and/or endurance exercise, vibration therapy, balance training, computerized training, etc.).
- The maximum funding amount available for the Mitochondrial Disease Research Grant is $45,000 per project (over the total duration of the project). At this time, funding is non-renewable.
- Successful projects will receive the level of funding requested.
- The proposed research must be conducted in Canada.
For further information and application instructions, please see the attached Mito Canada Request for Proposals document.
Deadline: December 15, 2014
The Canada Addiction Medicine Research Fellowship is a US National Institute on Drug Abuse (NIDA) funded research training fellowship in partnership with St. Paul’s Hospital, the University of British Columbia, and the Urban Health Research Initiative of the BC Centre for Excellence in HIV/AIDS. This fellowship will train addiction medicine physicians to develop the skills required for a career in addiction research. This new research training program provides $50,000 research fellowships for physicians who are involved in the care of alcohol- and drug-addicted patients. This part-time, one-year curriculum runs from July 1st to June 30th annually. Four positions are available for competitive candidates.
For additional details, please visit the website at http://addictionmedicinefellowship.org/research-fellowship/the-program/.
LOI Deadline: January 9, 2015
The ALS Association has announced a Request for Proposals for phase II clinical trials for novel, high-potential treatments for amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease.
The goal of this RFP is to expedite the process of bringing new treatments forward for testing in people with ALS and to measure whether a therapeutic agent is reaching its target. In the United States, ALS affects one in approximately 30,000 people, with 5,000 new diagnoses each year. There is currently one FDA-approved treatment for ALS, Riluzole (Rilutek), which was introduced in the early 1990s.
Grants of up to $1.5 million will be awarded for phase II clinical trials that include therapeutic interventions that have a pharmacodynamics marker that can measure whether the pathway of interest has been affected as well as a plan to collect samples for biomarker studies.
The program is open to academic-industry partnerships, including pharmaceutical, biotherapeutic/biotechnology companies, academic members of the NEALS Consortium, and ALS scientists around the world. Funding will cover direct costs only.
Letters of Intent must be received no later than January 9, 2015. Upon review, selected applicants will be invited to submit complete proposals, which will be due March 2, 2015.
For complete program guidelines and application procedures, visit the ALSA website.
AWARDS & HONOURS:
FoM Internal Deadline: February 13, 2015
The Japan Prize is a prestigious international award presented to individuals whose original and outstanding achievements are not only scientifically impressive, but have also served to promote peace and prosperity for all mankind.
The Prize is awarded by the Japan Prize Foundation. Since its inception in 1985, the Foundation has awarded 81 people from 13 countries.
In principle, the award is intended for a single person but small groups of researchers are also eligible. The person must be alive to be named a Japan Prize Laureate. A complete listing of the Laureates honored to date along with information about their research is available here.
1) Area: Physics, Chemistry and Engineering
Field: Materials and Production
2) Area: Life Science, Agriculture and Biological Environment
Field: Biological Production and Biological Environment
Nominations must be submitted to firstname.lastname@example.org by the internal deadline (4 pm on February 13, 2015) for internal adjudication by an adjudication committee. Please ensure that nomination packages include the following information:
- Candidate name, nationality and place of work;
- The title of the achievement (within 100 characters);
- The description of the achievement (within 4,000 characters);
- The description of the contribution to society based on the achievement (within 4,000 characters);
- Candidate’s CV and publication list; and
- Any additional supplemental information.
Questions should be directed to James Beresford, Manager of Governance and Recognition at email@example.com or 604-827-0327.
Date & Time: November 26, 2014; 6-8pm
Location: Alice MacKay Room, Lower Level, Central Library, 350 West Georgia St., Vancouver BC
Learn about the link between obesity and diabetes, current treatment options for type 2 diabetes and how genetics and personalized medicine will inform better treatments in the near future.
Timothy Kieffer, PhD
Group Leader and Professor, UBC LSI Diabetes Research Group
Depts of Cellular & Physiological Sciences and Surgery
Canadian Diabetes Association Scholar
Insulin – The good, the bad and the complicated
Jim Johnson, PhD
Associate Professor, UBC LSI Diabetes Research Group
Dept of Cellular & Physiological Sciences
Do these genes make me fat?
Susanne Clee, PhD
Assistant Professor, UBC LSI Diabetes Research Group
Dept of Cellular & Physiological Sciences
New drugs in diabetes
Tom Elliott, MD
Medical Director, bcdiabetes.ca
Associate Professor of Medicine, UBC
Diabetes management – How do I do what my doctor asked me to do?
Gerri Klein, RN, MSN
Certified Diabetes Educator, bcdiabetes.ca
Please RSVP: http://lsi.ubc.ca/talks
The LSI Public Talks aim to help the public understand how our research has an impact on their lives and provides an opportunity to ask questions in an informal environment. The 2014-2015 series focuses on personalized medicine and how we are working to change clinical practice, improve health outcomes, and reduce health costs. Mark your calendars for the 2014-2015 series:
Wednesday, February 4, 2015 – Preventive Medicine; Molecular You
Wednesday, March 25, 2015 – World TB Day
The LSI Public Talks are delivered in partnership with the Vancouver Public Library and UBC’s Irving K. Barber Learning Centre.